Rheumatic disease and COVID-19

Affiliations

¹ Division of Rheumatology, Department of Medicine, University of Washington, Seattle, Washington, USA liew.jw@gmail.com.
² Department of Rheumatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

Comment

Jean W Liew et al. Ann Rheum Dis. 2021 Mar.

. 2021 Mar;80(3):e43.

doi: 10.1136/annrheumdis-2020-217674. Epub 2020 Jul 10.

¹ Division of Rheumatology, Department of Medicine, University of Washington, Seattle, Washington, USA liew.jw@gmail.com.
² Department of Rheumatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

No abstract available

Keywords: epidemiology; lupus erythematosus, systemic; outcome assessment, health care.

Conflict of interest statement

Competing interests: None declared.

Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies.
Monti S, Balduzzi S, Delvino P, Bellis E, Quadrelli VS, Montecucco C. Monti S, et al. Ann Rheum Dis. 2020 May;79(5):667-668. doi: 10.1136/annrheumdis-2020-217424. Epub 2020 Apr 2. Ann Rheum Dis. 2020. PMID: 32241793 Free PMC article. No abstract available.
SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment.
Joob B, Wiwanitkit V. Joob B, et al. Ann Rheum Dis. 2020 Jun;79(6):e61. doi: 10.1136/annrheumdis-2020-217506. Epub 2020 Apr 15. Ann Rheum Dis. 2020. PMID: 32295787 No abstract available.